These data demonstrate that inhibiting Fgr exacerbates cardiac functional impairment in the MI model, which is likely a consequence of the further reduction in PI3K/Akt phosphorylation levels induced by Fgr inhibition. This evidence concerns the gene AKT1 and myocardial infarction.